AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+13.39%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.92B
AUM Growth
+$1.92B
(+6.5%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
43%
Holding
144
New
9
Increased
16
Reduced
9
Closed
11
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$68.3M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$44.6M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$32.9M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$28.1M |
| 5 |
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
|
$25.7M |
Top Sells
| 1 |
argenx
ARGX
|
$88.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$87.5M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$23.9M |
| 4 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$16.3M |
| 5 |
Cytokinetics
CYTK
|
$13.3M |
Sector Composition
| 1 | Healthcare | 95.18% |
| 2 | Consumer Discretionary | 3.54% |
| 3 | Financials | 0.61% |
| 4 | Consumer Staples | 0.21% |
| 5 | Industrials | 0.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Lexicon Pharmaceuticals
LXRX
$400M
| $215M | 9.2% | 89,778,234 +18,599,870 | +26% | +$44.6M |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $92.5M | 3.95% | 1,325,000 +225,000 | +20% | +$15.7M |
|
|
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $87.6M | 3.74% | 650,000 | – | – |
|
|
4
Apellis Pharmaceuticals
APLS
$3.48B
| $68.3M | 2.91% | +1,000,000 | New | +$68.3M |
|
|
BLU
5
DELISTED
BELLUS Health Inc.
BLU
| $63.4M | 2.7% | 6,000,000 -1,000,000 | -14% | -$10.6M |
|
|
MORF
6
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $60.8M | 2.6% | 2,150,000 +500,000 | +30% | +$14.2M |
|
7
Scholar Rock
SRRK
$3.14B
| $60.6M | 2.59% | 8,750,034 | – | – |
|
|
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
| $58.6M | 2.5% | 2,053,403 +1,153,403 | +128% | +$32.9M |
|
9
Fate Therapeutics
FATE
$120M
| $58.3M | 2.49% | 2,600,000 | – | – |
|
|
WW
10
DELISTED
WW International
WW
| $58.2M | 2.49% | 14,818,300 | – | – |
|
|
CERE
11
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $56.5M | 2.41% | 2,000,000 +500,000 | +33% | +$14.1M |
|
|
IGMS
12
DELISTED
IGM Biosciences
IGMS
| $55.7M | 2.38% | 2,450,000 +450,000 | +23% | +$10.2M |
|
|
13
argenx
ARGX
$43.6B
| $53M | 2.26% | 150,000 -250,000 | -63% | -$88.3M |
|
|
14
Cytokinetics
CYTK
$4.23B
| $48.5M | 2.07% | 1,000,000 -275,000 | -22% | -$13.3M |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| $47.9M | 2.04% | 350,000 -175,000 | -33% | -$23.9M |
|
|
KLRS
16
Kalaris Therapeutics, Inc. Common Stock
KLRS
$76.3M
| $44M | 1.88% | 5,577,167 +3,253,796 | +140% | +$25.7M |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $41.8M | 1.78% | 4,000,000 | – | – |
|
18
Gossamer Bio
GOSS
$562M
| $38.9M | 1.66% | 3,246,624 +887,656 | +38% | +$10.6M |
|
19
Seer Inc
SEER
$115M
| $36.8M | 1.57% | 4,750,000 | – | – |
|
20
Krystal Biotech
KRYS
$4.27B
| $34.9M | 1.49% | 500,000 | – | – |
|
21
Kymera Therapeutics
KYMR
$2.95B
| $32.7M | 1.39% | 1,500,000 +500,000 | +50% | +$10.9M |
|
22
Relay Therapeutics
RLAY
$619M
| $32.5M | 1.39% | 1,454,716 +754,716 | +108% | +$16.9M |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $29.4M | 1.25% | 750,000 +300,000 | +67% | +$11.7M |
|
|
KRTX
24
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $28.1M | 1.2% | +125,000 | New | +$28.1M |
|
25
Erasca
ERAS
$445M
| $24.7M | 1.06% | 3,172,221 | – | – |
|